Strategy for Treatment of Infected Diabetic Foot Ulcers

Matrix metalloproteinase 9 facilitates Zika virus invasion of the testis by modulating the integrity of the blood-testis barrier

(2020) Lixia Hui et al.   PLoS Pathogens

WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition

(2019) Pouya Saeedi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Ease of Application and Removal of Common Total-Contact Cast Systems Used in the Podiatric Medical Community

(2019) Kathy Ludwig et al.   JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION

Hyperbaric oxygen therapy accelerates wound healing in diabetic mice by decreasing active matrix metalloproteinase‐9

(2019) Trung T. Nguyen et al.   WOUND REPAIR AND REGENERATION

Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing

(2018) Trung T. Nguyen et al.   JOURNAL OF MEDICINAL CHEMISTRY

IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes

(2016) Benjamin A. Lipsky et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury

(2015) Mijoon Lee et al.   ACS Chemical Neuroscience

Acceleration of diabetic wound healing using a novel protease–anti-protease combination therapy

(2015) Ming Gao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization of a selective inhibitor for matrix metalloproteinase-8 (MMP-8)

(2014) Derong Ding et al.   MedChemComm

IL-6 in Inflammation, Immunity, and Disease

(2014) T. Tanaka et al.   Cold Spring Harbor Perspectives in Biology

A Chemical Biological Strategy to Facilitate Diabetic Wound Healing

(2013) Major Gooyit et al.   ACS Chemical Biology

Water-Soluble MMP-9 Inhibitor Prodrug Generates Active Metabolites That Cross the Blood–Brain Barrier

(2013) Wei Song et al.   ACS Chemical Neuroscience

O-Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors that Cross the Blood–Brain Barrier

(2013) Major Gooyit et al.   JOURNAL OF MEDICINAL CHEMISTRY

Matrix Metalloproteinase-9: Many Shades of Function in Cardiovascular Disease

(2013) Andriy Yabluchanskiy et al.   PHYSIOLOGY

Structure–Activity Relationship for Thiirane-Based Gelatinase Inhibitors

(2012) Mijoon Lee et al.   ACS Medicinal Chemistry Letters

Selective Water-Soluble Gelatinase Inhibitor Prodrugs

(2011) Major Gooyit et al.   JOURNAL OF MEDICINAL CHEMISTRY

Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation

(2010) P. van Battum et al.   DIABETIC MEDICINE

Active Site Ring-Opening of a Thiirane Moiety and Picomolar Inhibition of Gelatinases

(2009) Christopher Forbes et al.   Chemical Biology & Drug Design

Synthesis, Kinetic Characterization and Metabolism of Diastereomeric 2-(1-(4-Phenoxyphenylsulfonyl)ethyl)thiiranes as Potent Gelatinase and MT1-MMP Inhibitors

(2009) Major Gooyit et al.   Chemical Biology & Drug Design

A Potent Gelatinase Inhibitor with Anti-Tumor-Invasive Activity and its Metabolic Disposition

(2009) Mijoon Lee et al.   Chemical Biology & Drug Design

Extra Binding Region Induced by Non-Zinc Chelating Inhibitors into the S1′ Subsite of Matrix Metalloproteinase 8 (MMP-8)†

(2009) Giorgio Pochetti et al.   JOURNAL OF MEDICINAL CHEMISTRY

Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers

(2008) J.-L. Richard et al.   DIABETES & METABOLISM

Biofilms in chronic wounds

(2008) Garth A. James et al.   WOUND REPAIR AND REGENERATION